These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30868763)

  • 1. Identification of upstream culture conditions and harvest time parameters that affect host cell protein clearance.
    Wilson LJ; Lewis W; Kucia-Tran R; Bracewell DG
    Biotechnol Prog; 2019 May; 35(3):e2805. PubMed ID: 30868763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and classification of host cell proteins during biopharmaceutical process development.
    Wilson LJ; Lewis W; Kucia-Tran R; Bracewell DG
    Biotechnol Prog; 2022 Jan; 38(1):e3224. PubMed ID: 34751518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
    Goey CH; Bell D; Kontoravdi C
    MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Sequence, Display, and Mode of Operation of IgG-Binding Peptide Ligands to Develop Robust, High-Capacity Affinity Adsorbents That Afford High IgG Product Quality.
    Islam T; Naik AD; Hashimoto Y; Menegatti S; Carbonell RG
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptide ligands for antibody purification provide superior clearance of host cell protein impurities.
    Reese HR; Xiao X; Shanahan CC; Chu W; Van Den Driessche GA; Fourches D; Carbonell RG; Hall CK; Menegatti S
    J Chromatogr A; 2020 Aug; 1625():461237. PubMed ID: 32709313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of B. cereus cereulide toxin from monoclonal antibody bioprocess feed via two-step Protein A affinity and multimodal chromatography.
    Wetterhall M; Grönberg A; Grönlund S; Björkman T; Sandberg L; Musunuri S; Chaloupka K; Gammell P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():194-202. PubMed ID: 31059926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization and application of caprylic acid precipitation in the purification of monoclonal antibody].
    Yang Z; Zhou J
    Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3757-3771. PubMed ID: 37805852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
    Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
    Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture.
    Brechmann NA; Eriksson PO; Eriksson K; Oscarsson S; Buijs J; Shokri A; Hjälm G; Chotteau V
    Biotechnol Prog; 2019 May; 35(3):e2775. PubMed ID: 30629859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hydrolysates on monoclonal antibody productivity, purification and quality in Chinese hamster ovary cells.
    Ho SC; Nian R; Woen S; Chng J; Zhang P; Yang Y
    J Biosci Bioeng; 2016 Oct; 122(4):499-506. PubMed ID: 27067279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a filter train for precipitate removal in monoclonal antibody downstream processing.
    Kandula S; Babu S; Jin M; Shukla AA
    Biotechnol Appl Biochem; 2009 Oct; 54(3):149-55. PubMed ID: 19656082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antiapoptosis genes on clarification performance.
    Potty AS; Xenopoulos A; Patel S; Prentice H; Dileo A
    Biotechnol Prog; 2014; 30(1):100-7. PubMed ID: 24124050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
    Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
    Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of cultivation conditions in spin tubes for Chinese hamster ovary cells producing erythropoietin and the comparison of glycosylation patterns in different cultivation vessels.
    Strnad J; Brinc M; Spudić V; Jelnikar N; Mirnik L; Carman B; Kravanja Z
    Biotechnol Prog; 2010; 26(3):653-63. PubMed ID: 20544713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.